Children's cancers, Neuroblastoma
Results
Phase 3
This trial looked at different treatments for high risk neuroblastoma. High risk means the cancer is more likely to grow or come back (recur) after treatment.
This trial was open for children and young people up to the age of 21 to join between 2002 and 2017. The team published the results in 2018, 2020 and 2025.
Cancer Research UK supported this trial.
Recruitment start: 1 December 2002
Recruitment end: 8 June 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Martin Elliot
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Cancer Research UK Children's Cancer Trials Team, University of Birmingham
This is Cancer Research UK trial number CRUK/02/013.
Last reviewed: 15 Oct 2026
CRUK internal database number: 239
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
